RefleXion Medical and HealthMyne have entered a partnership deal enabling the use of HealthMyne's radiomics and image analysis algorithms to evaluate Reflexion biology-guided radiotherapy system-derived PET and CT data to develop personalized radiation therapy based on patients' tumor characteristics and radiotherapy response. Such therapies will be more beneficial in cancer treatment, compared with standard protocol-based radiotherapy, according to the companies.
RefleXion, HealthMyne enter cancer radiomics partnership
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.